ARK Investment Management - ENLIVEX THERAPEUTICS LTD ownership

ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 7 filers reported holding ENLIVEX THERAPEUTICS LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of ENLIVEX THERAPEUTICS LTD
ValueSharesWeighting
Q2 2022$1,658,000
-31.7%
331,001
-23.8%
0.01%0.0%
Q1 2022$2,428,000
+11.2%
434,343
+24.3%
0.01%
+42.9%
Q4 2021$2,183,000
-51.7%
349,308
-23.7%
0.01%
-36.4%
Q3 2021$4,523,000
-1.3%
457,797
-11.1%
0.01%
+22.2%
Q2 2021$4,582,000
-13.3%
514,807
+8.1%
0.01%
-10.0%
Q1 2021$5,283,000
+1535.6%
476,414
+1136.3%
0.01%
+25.0%
Q4 2019$323,00038,5360.01%
Other shareholders
ENLIVEX THERAPEUTICS LTD shareholders Q1 2020
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 82,500$735,0000.38%
Golden Green, Inc. 46,020$410,0000.31%
ARK Investment Management 514,807$4,582,0000.01%
Compagnie Lombard Odier SCmA 25,000$220,0000.01%
Banque Cantonale Vaudoise 10,000$89,0000.00%
EDMOND DE ROTHSCHILD HOLDING S.A. 13,000$116,0000.00%
Renaissance Technologies 195,706$1,742,0000.00%
Steward Partners Investment Advisory, LLC 15,500$136,0000.00%
BANK OF AMERICA CORP /DE/ 897$8,0000.00%
WELLS FARGO & COMPANY/MN 19,491$174,0000.00%
View complete list of ENLIVEX THERAPEUTICS LTD shareholders